BTLA and hepatocellular carcinoma: The correlation between ADAM9 expression and expression of immune checkpoint molecules (PD-1, TIM-3, lymphocyte activation gene-3 (LAG-3) and B and T lymphocyte attenuator (BTLA)) in HCC patients (n = 370) from TCGA database was analyzed.